Stockreport

CF Foundation Invests Up to $15 million in ReCode Therapeutics to Develop a Gene Editing Therapy [Yahoo! Finance]

Intellia Therapeutics, Inc.  (NTLA) 
Last intellia therapeutics, inc. earnings: 2/27 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.intelliatx.com/investor-overview
PDF to transport gene editing cargo to the lung cells in people with cystic fibrosis. BETHESDA, Md., November 18, 2024 BUSINESS WIRE )--The Cystic Fibrosis Foundation has [Read more]